 Shares of Oric Pharmaceuticals Inc. ORIC, 2.04 soared about 56 in premarket trading on Thursday, the day after the company said it will collaborate with Pfizer Inc. PFE, 0.66 to develop a multiple myeloma therapeutic candidate. Pfizer will pay 4.65 per share for 5,376,344 of Orics common shares, for a total of 25 million. 